Inactive Instrument

Press Releases Stellar Biotechnologies Inc Toronto S.E.

Equities

KLH

CA85855A2039

Press Releases

Unlock all the news: Be the first to know and act before the market!

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference	Apr. 12	AQ
Edesa Biotech to Participate in Barclays Global Healthcare Conference	Mar. 08	AQ
Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech's ARDS Drug	23-10-26	AQ
Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate	23-09-29	AQ
Edesa Biotech to Participate in Swiss Biotech Day	23-04-21	AQ
Edesa Biotech - The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate	23-04-05	AQ
EDESA BIOTECH, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-03-27	AQ
EDESA BIOTECH, INC. : Regulation FD Disclosure (form 8-K)	23-03-13	AQ
Edesa Biotech Reports Fiscal 1st Quarter 2023 Results	23-02-13	AQ
EDESA BIOTECH, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23-02-10	AQ
EDESA BIOTECH, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-02-10	AQ
Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug	23-01-18	AQ
Edesa Biotech Reports Fiscal Year 2022 Results	22-12-19	AQ
EDESA BIOTECH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	22-12-16	AQ
EDESA BIOTECH, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	22-12-16	AQ
Edesa Biotech to Participate in the 2022 Cantor Fitzgerald Dermatology Conference	22-12-05	AQ
EDESA BIOTECH, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	22-11-03	AQ
Edesa Biotech Reports Statistically Significant Mortality Reductions in Phase 2 ARDS Drug Study	22-10-03	AQ
Edesa Biotech : Reports Fiscal 3rd Quarter 2022 Results - Form 8-K	22-08-12	PU
EDESA BIOTECH, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-08-12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Stellar Biotechnologies Inc Toronto S.E.

Equities

KLH

CA85855A2039

Press Releases

Filters